| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Revankar Shriram | SVP, Advanced Technology Group | C/O DOLBY LABORATORIES, INC., 1275 MARKET STREET, SAN FRANCISCO | /s/ Daniel Rodriguez as Attorney-in-Fact for Shriram Revankar | 20 May 2025 | 0001928994 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | DLB | Class A Common Stock | Tax liability | $334,372 | -4,329 | -5.3% | $77.24 | 77,435 | 16 May 2025 | Direct | F1, F2, F3 |
| Id | Content |
|---|---|
| F1 | In accordance with Rule 16b-3, shares reported as disposed of were withheld by the Issuer in a transaction exempt from Section 16(b) and not issued to the reporting person in order to cover withholding taxes incidental to the vesting of restricted stock units. |
| F2 | Shares held following the reported transactions include 47,766 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. |
| F3 | Shares include 351 shares acquired under the Issuer's Employee Stock Purchase Plan on May 15, 2025. |